1 General Purpose
In studies of different treatments
often parallel groups receiving different treatments are included.
Unlike repeated measures studies (Chaps. 9, 10, 11, 12), they involve independent
treatment effects with a zero correlation between the treatments.
One way analysis of variance (ANOVA) is appropriate for
analysis.
2 Schematic Overview of Type of Data File

3 Primary Scientific Question
Do parallel treatment modalities
produce significantly different mean magnitudes of treatment
effects.
4 Data Example
Hours of sleep
|
Group
|
Age (years)
|
Gender
|
Co-morbidity
|
6,00
|
0,00
|
45,00
|
0,00
|
1,00
|
7,10
|
0,00
|
45,00
|
0,00
|
1,00
|
8,10
|
0,00
|
46,00
|
0,00
|
0,00
|
7,50
|
0,00
|
37,00
|
0,00
|
0,00
|
6,40
|
0,00
|
48,00
|
0,00
|
1,00
|
7,90
|
0,00
|
76,00
|
1,00
|
1,00
|
6,80
|
0,00
|
56,00
|
1,00
|
1,00
|
6,60
|
0,00
|
54,00
|
1,00
|
0,00
|
7,30
|
0,00
|
63,00
|
1,00
|
0,00
|
5,60
|
0,00
|
75,00
|
0,00
|
0,00
|
The entire data file is in
extras.springer.com, and is entitled
“chapter13unpairedcontinuousmultiplegroups”. Start by opening the
data file in SPSS.
5 One Way ANOVA
For analysis the module Compare Means
is required. It consists of the following statistical models:
-
Means,
-
One-Sample T-Test,
-
Independent-Samples T-Test,
-
Paired-Samples T-Test and
-
One Way ANOVA.
Command:
-
Analyze....Compare Means....One-way Anova....Dependent lists: effect treat.... Factor: enter group....click OK.
ANOVA effect treatment
Sum of squares
|
df
|
Mean square
|
F
|
Sig.
|
|
---|---|---|---|---|---|
Between groups
|
37,856
|
2
|
18,928
|
14,110
|
,000
|
Within groups
|
36,219
|
27
|
1,341
|
||
Total
|
74,075
|
29
|
A significant difference between the
three treatments has been demonstrated with a p-value of 0,0001.
Like with the paired data of the previous chapter the conclusion is
drawn: a difference exists, but we don’t yet know whether the
difference is between treatments 1 and 2, 2 and 3, or 1 and 3.
Three subsequent unpaired t-tests are required to find out.
Similarly to the tests of Chap. 5, a smaller p-value for rejecting
the null-hypothesis is recommended, for example, 0,01 instead of
0,05. This is, because with multiple testing the chance of type 1
errors of finding a difference where there is none is enlarged, and
this chance has to be adjusted.
Like the Friedman test can be applied
for comparing three or more paired samples as a non-Gaussian
alternative to the paired ANOVA test (see Chap. 6), the Kruskal-Wallis test can be
used as a non-Gaussian alternative to the above unpaired ANOVA
test.
6 Alternative Test: Kruskal-Wallis Test
For analysis the statistical model K
Independent Samples in the module Nonparametric Tests is required.
Command:
-
Analyze....Nonparametric....K Independent Samples....Test Variable List: effect treatment....Grouping Variable: group....click Define range....Minimum: enter 0....Maximum: enter 2....Continue....mark: Kruskal-Wallis....click OK.
Test statisticsa,b
Effect treatment
|
|
---|---|
Chi-Square
|
15,171
|
df
|
2
|
Asymp. Sig.
|
,001
|
The Kruskal-Wallis test is significant
with a p-value of no less than 0,001. This means that the three
treatments are very significantly different from one another.
7 Conclusion
The analyses show that a significant
difference between the three treatments exists. This is an overall
result. We don’t know where the difference is. In order to find out
whether the difference is between the treatments 1 and 2, 2 and 3,
or 1 and 3 additional one by one treatment analyses are required.
With one way ANOVA the advice is to perform three additional
unpaired t-tests, with nonparametric testing the advice is to
perform three Mann-Whitney tests to find out. Again, a subsequent
reduction of the p-value or a Bonferroni test is appropriate.
8 Note
More background, theoretical, and
mathematical information is available in Statistics applied to
clinical studies 5th edition, Chap. 2, Springer Heidelberg Germany,
2012, from the same authors.